Before going into detail, it has to he stressed that the number of patients was small and the duration of the trial limited to 5 days.The tetra:epam regimen was followed strictly (see Table 1 ), and no further increase in dose was allowed, even when the relaxation index decreased after an initial elevation.
All nine patients suffered from spastic hemiparesis or paraparesis with an Ashworth grade of the knee extensors and flexors on day -1 (before the beginning of medication) ranging from 1 to 3. Spastic hemiparesis of long standing was present in case 1 and of only several Tables 3 and Table 4 All patients except 1 and 9 reported that their walking ability had slightly or moderately improved toward flie end ot the 5-day trial. In patient 9 ataxia became (Figure 3 ). This might he explained hy the inclusion of patient 1 with hemiplegia, who did not respond to tetra:epam.
Discussion
Tetrazepam is an estahtished antispastic drug with a good side-effect profile (2, 7, 22 
